NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ballard Power Systems, Inc. (NASDAQ:BLDP), Reading International Inc (NASDAQ:RDI), Odonate Therapeutics, Inc. (NASDAQ:ODT), Stitch Fix, Inc. (NASDAQ:SFIX), Summit Therapeutics PLC (NASDAQ:SMMT), and Cellectis S.A. (NASDAQ:CLLS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
BLDP DOWNLOAD: http://Fundamental-Markets.com/register/?so=BLDP
RDI DOWNLOAD: http://Fundamental-Markets.com/register/?so=RDI
ODT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ODT
SFIX DOWNLOAD: http://Fundamental-Markets.com/register/?so=SFIX
SMMT DOWNLOAD: http://Fundamental-Markets.com/register/?so=SMMT
CLLS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLLS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Ballard Power Systems, Inc. (NASDAQ:BLDP), Reading International Inc (NASDAQ:RDI), Odonate Therapeutics, Inc. (NASDAQ:ODT), Stitch Fix, Inc. (NASDAQ:SFIX), Summit Therapeutics PLC (NASDAQ:SMMT), and Cellectis S.A. (NASDAQ:CLLS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
BALLARD POWER SYSTEMS, INC. (BLDP) REPORT OVERVIEW
Ballard Power's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Ballard Power reported revenue of $26.45MM vs $26.52MM (down 0.29%) and basic earnings per share -$0.02 vs -$0.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ballard Power reported revenue of $121.29MM vs $85.27MM (up 42.24%) and basic earnings per share -$0.05 vs -$0.13. Ballard Power is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is -$0.01 and is expected to report on February 27th, 2019.
To read the full Ballard Power Systems, Inc. (BLDP) report, download it here: http://Fundamental-Markets.com/register/?so=BLDP
-----------------------------------------
READING INTERNATIONAL INC (RDI) REPORT OVERVIEW
Reading International's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Reading International reported revenue of $84.22MM vs $72.41MM (up 16.31%) and basic earnings per share $0.22 vs $0.82 (down 73.17%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Reading International reported revenue of $279.73MM vs $270.47MM (up 3.42%) and basic earnings per share $1.35 vs $0.40 (up 237.50%). Reading International is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.07. The estimated EPS forecast for the next fiscal year is $0.73 and is expected to report on March 15th, 2019.
To read the full Reading International Inc (RDI) report, download it here: http://Fundamental-Markets.com/register/?so=RDI
-----------------------------------------
ODONATE THERAPEUTICS, INC. (ODT) REPORT OVERVIEW
Odonate Therapeutics' Recent Financial Performance
Odonate Therapeutics is expected to report earnings on October 29th, 2018. The report will be for the fiscal period ending September 30th, 2018. The estimated EPS forecast for the next fiscal year is -$3.38 and is expected to report on February 13th, 2019.
To read the full Odonate Therapeutics, Inc. (ODT) report, download it here: http://Fundamental-Markets.com/register/?so=ODT
-----------------------------------------
STITCH FIX, INC. (SFIX) REPORT OVERVIEW
Stitch Fix's Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Stitch Fix reported revenue of $316.74MM vs $245.08MM (up 29.24%) and basic earnings per share $0.10 vs -$0.38. For the twelve months ended July 31st, 2017 vs July 31st, 2016, Stitch Fix reported revenue of $977.14MM vs $730.31MM (up 33.80%) and basic earnings per share -$0.02 vs $0.36. Stitch Fix is expected to report earnings on October 1st, 2018. The report will be for the fiscal period ending July 31st, 2018. The estimated EPS forecast for the next fiscal year is $0.20 and is expected to report on October 1st, 2018.
To read the full Stitch Fix, Inc. (SFIX) report, download it here: http://Fundamental-Markets.com/register/?so=SFIX
-----------------------------------------
SUMMIT THERAPEUTICS PLC (SMMT) REPORT OVERVIEW
Summit Therapeutics' Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Summit Therapeutics reported revenue of $5.33MM vs $2.24MM (up 138.24%) and basic earnings per share -$0.55 vs -$0.50. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Summit Therapeutics reported revenue of $33.08MM vs $3.08MM (up 973.16%) and basic earnings per share -$0.70 vs -$2.32. Summit Therapeutics is expected to report earnings on August 30th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $1.10. The estimated EPS forecast for the next fiscal year is -$1.70 and is expected to report on April 10th, 2019.
To read the full Summit Therapeutics PLC (SMMT) report, download it here: http://Fundamental-Markets.com/register/?so=SMMT
-----------------------------------------
CELLECTIS S.A. (CLLS) REPORT OVERVIEW
Cellectis S.A's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Cellectis S.A reported revenue of $8.34MM vs $8.97MM (down 6.97%) and basic earnings per share -$0.17 vs -$0.75. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cellectis S.A reported revenue of $33.72MM vs $56.44MM (down 40.27%) and basic earnings per share -$2.78 vs -$1.91. Cellectis S.A is expected to report earnings on November 12th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.73. The estimated EPS forecast for the next fiscal year is -$2.36 and is expected to report on March 11th, 2019.
To read the full Cellectis S.A. (CLLS) report, download it here: http://Fundamental-Markets.com/register/?so=CLLS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.